Akman, T. Et Al. 2015. The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy. MEDICAL ONCOLOGY , vol.32, no.1 .

Akman, T., ÖZTOP, İ., BAŞBINAR, Y., Akbarpour, M., Unal, O. U., Oflazoglu, U., ... ELLİDOKUZ, H.(2015). The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy. MEDICAL ONCOLOGY , vol.32, no.1.

Akman, Tulay Et Al. "The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy," MEDICAL ONCOLOGY , vol.32, no.1, 2015

Akman, Tulay Et Al. "The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy." MEDICAL ONCOLOGY , vol.32, no.1, 2015

Akman, T. Et Al. (2015) . "The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy." MEDICAL ONCOLOGY , vol.32, no.1.

@article{article, author={Tulay Akman Et Al. }, title={The role of BRAF mutation in patients with high-risk malignant melanoma treated with high-dose adjuvant interferon therapy}, journal={MEDICAL ONCOLOGY}, year=2015}